California is committed to 33 percent energy from renewable resources by 2020. With that deadline fast approaching, researchers across the state are busy exploring options.
Solar energy is attractive but for widespread adoption, it requires transformation into a storable form. This week in ACS Central Science, researchers report that nanowires made from multiple metal oxides could put solar ahead in this race.
One way to harness solar power for broader use is through photoelectrochemical (PEC) water splitting that provides hydrogen for fuel cells. Many materials that can perform the reaction exist, but most of these candidates suffer from issues, ranging from efficiency to stability and cost.
Peidong Yang and colleagues designed a system where nanowires from one of the most commonly used materials (TiO2) acts as a “host” for “guest” nanoparticles from another oxide called BiVO4. BiVO4 is a newly introduced material that is among the best ones for absorbing light and performing the water splitting reaction, but does not carry charge well while TiO2 is stable, cheap and an efficient charge carrier but does not absorb light well.
Together with a unique studded nanowire architecture, the new system works better than either material alone.
The authors state their approach can be used to improve the efficiencies of other photoconversion materials.
We report the use of Ta:TiO2|BiVO4 as a photoanode for use in solar water splitting cells. This host−guest system makes use of the favorable band alignment between the two semiconductors. The nanowire architecture allows for simultaneously high light absorption and carrier collection for efficient solar water oxidation.
Metal oxides that absorb visible light are attractive for use as photoanodes in photoelectrosynthetic cells. However, their performance is often limited by poor charge carrier transport. We show that this problem can be addressed by using separate materials for light absorption and carrier transport. Here, we report a Ta:TiO2|BiVO4 nanowire photoanode, in which BiVO4 acts as a visible light-absorber and Ta:TiO2 acts as a high surface area electron conductor. Electrochemical and spectroscopic measurements provide experimental evidence for the type II band alignment necessary for favorable electron transfer from BiVO4 to TiO2. The host–guest nanowire architecture presented here allows for simultaneously high light absorption and carrier collection efficiency, with an onset of anodic photocurrent near 0.2 V vs RHE, and a photocurrent density of 2.1 mA/cm2 at 1.23 V vs RHE.
Article adapted from a American Chemical Society news release. To Read the FULL release, please click on the link provided below.
Publication: TiO2/BiVO4 Nanowire Heterostructure Photoanodes Based on Type II Band Alignment. Resasco, J et al. ACS Central Science (3 February, 2016): Click here to view.
Genesis Nanotechnology – “Great Things from Small Things”
Many cancer patients survive treatment only to have a recurrence within a few years. Recurrences and tumor spreading are likely due to cancer stem cells that can be tough to kill with conventional cancer drugs. But now researchers have designed nanoparticles that specifically target these hardy cells to deliver a drug. The nanoparticle treatment, reported in the journal ACS Nano, worked far better than the drug alone in mice.
Anti-cancer drugs can often shrink tumors but don’t kill cancer stem cells (CSCs). Although CSCs might only make up a small part of a tumor, their resistance to drugs allows them to persist. They can then cause a tumor to regrow or spread cancerous cells throughout the body. Xiaoming He and colleagues wanted to develop a nanoparticle system to overcome these cells’ defenses.
The researchers packaged the anti-cancer drug doxorubicin into nanoparticles coated with chitosan, a natural polysaccharide that can specifically target CSCs. Once in the acidic environment of the tumor, the nanoparticles degraded and released the drug. Tests on tiny, tissue-like clumps of both normal and cancer stem cells in vitro and on human breast tumors grown in mice showed the therapy successfully killed CSCs and destroyed tumors. The mice showed no obvious side effects.
Explore further: Nano packages for anti-cancer drug delivery
More information: Chitosan-Decorated Doxorubicin-Encapsulated Nanoparticle Targets and Eliminates Tumor Reinitiating Cancer Stem-like Cells ACS Nano, Article ASAP
Tumor reinitiating cancer stem-like cells are responsible for cancer recurrence associated with conventional chemotherapy. We developed a doxorubicin-encapsulated polymeric nanoparticle surface-decorated with chitosan that can specifically target the CD44 receptors of these cells. This nanoparticle system was engineered to release the doxorubicin in acidic environments, which occurs when the nanoparticles are localized in the acidic tumor microenvironment and when they are internalized and localized in the cellular endosomes/lysosomes. This nanoparticle design strategy increases the cytotoxicity of the doxorubicin by six times in comparison to the use of free doxorubicin for eliminating CD44+ cancer stem-like cells residing in 3D mammary tumor spheroids (i.e., mammospheres). We further show these nanoparticles reduced the size of tumors in an orthotopic xenograft tumor model with no evident systemic toxicity. The development of nanoparticle system to target cancer stem-like cells with low systemic toxicity provides a new treatment arsenal for improving the survival of cancer patients.